Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanos Kalomoiris

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Stem Cells (Dayton, Ohio)|September 8, 2011
Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapyFernando A Fierro, Stefanos Kalomoiris, Claus S Sondergaard, et al.
Stem Cells (Dayton, Ohio)|May 27, 2014
Concise review: MicroRNA function in multipotent mesenchymal stromal cellsElizabeth A Clark, Stefanos Kalomoiris, Jan A Nolta, et al.
Journal of Cellular Biochemistry|July 28, 2015
Mesenchymal Stem Cells Respond to Hypoxia by Increasing DiacylglycerolsKinga Lakatos, Stefanos Kalomoiris, Béla Merkely, et al.
Journal of Cellular Biochemistry|February 19, 2016
Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem CellsStefanos Kalomoiris, Andrew C Cicchetto, Kinga Lakatos, et al.
Human Gene Therapy Methods|December 11, 2012
CD25 preselective anti-HIV vectors for improved HIV gene therapyStefanos Kalomoiris, Je'tai Lawson, Rachel X Chen, et al.
Stem Cells (Dayton, Ohio)|February 24, 2015
Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivoJulie Beegle, Kinga Lakatos, Stefanos Kalomoiris, et al.
Advanced Drug Delivery Reviews|October 6, 2010
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factorsTodd Meyerrose, Scott Olson, Suzanne Pontow, et al.
Tissue Engineering. Part A|February 1, 2011
Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cellsWilliam Gruenloh, Amal Kambal, Claus Sondergaard, et al.
Molecular and Cellular Neurosciences|December 27, 2011
Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtinScott D Olson, Amal Kambal, Kari Pollock, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cellsAmal Kambal, Gaela Mitchell, Whitney Cary, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Stem Cells (Dayton, Ohio)|September 8, 2011
Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapyFernando A Fierro, Stefanos Kalomoiris, Claus S Sondergaard, et al.
Stem Cells (Dayton, Ohio)|May 27, 2014
Concise review: MicroRNA function in multipotent mesenchymal stromal cellsElizabeth A Clark, Stefanos Kalomoiris, Jan A Nolta, et al.
Journal of Cellular Biochemistry|July 28, 2015
Mesenchymal Stem Cells Respond to Hypoxia by Increasing DiacylglycerolsKinga Lakatos, Stefanos Kalomoiris, Béla Merkely, et al.
Journal of Cellular Biochemistry|February 19, 2016
Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem CellsStefanos Kalomoiris, Andrew C Cicchetto, Kinga Lakatos, et al.
Human Gene Therapy Methods|December 11, 2012
CD25 preselective anti-HIV vectors for improved HIV gene therapyStefanos Kalomoiris, Je'tai Lawson, Rachel X Chen, et al.
Stem Cells (Dayton, Ohio)|February 24, 2015
Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivoJulie Beegle, Kinga Lakatos, Stefanos Kalomoiris, et al.
Advanced Drug Delivery Reviews|October 6, 2010
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factorsTodd Meyerrose, Scott Olson, Suzanne Pontow, et al.
Tissue Engineering. Part A|February 1, 2011
Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cellsWilliam Gruenloh, Amal Kambal, Claus Sondergaard, et al.
Molecular and Cellular Neurosciences|December 27, 2011
Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtinScott D Olson, Amal Kambal, Kari Pollock, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cellsAmal Kambal, Gaela Mitchell, Whitney Cary, et al.
Pageof 2